Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)62

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)22

Views

Views
May 20251
June 20250
July 20258
August 20250
September 20252
October 20256
November 20255
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil7
United Kingdom5
Peru2
United States2
Argentina2
Austria1
Ecuador1
Spain1
Morocco1
 

Top cities views

Views
Lima2
Arroio Grande1
Buenos Aires1
Casablanca1
Foz do Iguaçu1
Hartlepool1
Palhoça1
Pelotas1
Portoviejo1
Poté1